Warren Buffett fit · Wonderful businesses at fair prices
Is Xeris Biopharma Holdings, Inc. Common Stock (XERS) a Warren Buffett Stock?
Low Buffett fit — meets only 4/9 criteria; valuation, moat, or financial health flags risk.
23/100
FNot a fit
4/9 criteria passed
Warren Buffett's Criteria, Applied to XERS
ROIC ≥ 15%
key-13.3%
Gross margin ≥ 40%
key83.5%
Owner earnings yield ≥ 5%
key-11.0%
5y profitable
How XERS Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.36B
P/E (TTM)
92.7x
ROIC (TTM)
12.84%
Gross margin
81.59%
Other Warren Buffett fit reports
Frequently Asked Questions
What is XERS's Warren Buffett fit score?
XERS scores 23/100 on our Warren Buffett fit engine — grade F. Low Buffett fit — meets only 4/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own XERS?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends XERS.
How often is this score updated?
XERS's Warren Buffett fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends XERS.